US FDA Emphasizes Timesavers In New eCopy Guidance For Medical Devices
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration's medical device center has again updated its electronic copy (eCopy) guidance for industry to highlight tools that it believes will speed up the premarket submissions and review process1. The new document, published on Dec. 3, clarifies how the center wants sponsors to submit PDF files, spotlights a submission validation tool and includes other tips to reduce unnecessary eCopy holds that can delay submissions.
You may also be interested in...
Medical Device Regulations In Latin America And The Way Forward
Akhila Krishnan reviews the different regulatory requirements for medical devices in five Latin American countries and discusses how harmonization initiatives will make things easier for manufacturers in this guest column.
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.